Time to Disaggregate “Asian American” to Address Disparities in Heart Failure Risk
No abstract yet
We only have this paper's title and publication details.
Read it at the sourceAsk about this paper
Answers are grounded in this paper and cite their sources.
Key expert perspectives
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“The disaggregation of Asian American research data is essential to understand the drivers of intragroup heterogeneity in appropriate heart failure treatment, and ultimately, to formulate actionable policy and clinical interventions in promoting equity for all.”
“Clinical trials should incorporate explicit goals for racial and ethnic diversity to better reflect the populations that will ultimately receive these therapies. Despite the global nature of many studies, Asian representation remains limited or inappropriately generalized.”
“As this population rapidly grows, understanding their experiences of healthcare and of health and disease will become increasingly important.”
Discussion
No takes yet. Share an insight, caveat, or question.
Cite This Study
Lee et al. (2025) studied this question.